Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.35 USD | -0.05% |
|
-4.04% | -23.01% |
Jul. 01 | Orion, Merck & Co. Convert Agreement into Exclusive Global License to Opevesostat | MT |
Jul. 01 | Merck, Orion Convert Ongoing Collaboration Into Exclusive Global License for Opevesostat | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.01% | 1.24B | |
+18.91% | 67.35B | |
-4.68% | 45.56B | |
+23.36% | 44.14B | |
+38.09% | 28.89B | |
+9.62% | 19.28B | |
+15.26% | 17.32B | |
-26.04% | 14.85B | |
-13.27% | 14.72B | |
-29.84% | 12.07B |
- Stock Market
- Equities
- OEC Stock
- News Orion S.A.
- Orion Engineered Carbons Names Jeffrey Glajch Finance Chief